Results 261 to 270 of about 131,241 (336)

Hepatocyte nuclear factor 4 alpha immunocytochemistry: A useful marker for detecting endocervical glandular lesions in alcohol‐fixed smears

Cancer Cytopathology, Volume 133, Issue 8, August 2025.
Abstract Background Hepatocyte nuclear factor 4 alpha (HNF4α) contributes to tumorigenesis and cancer progression. This study evaluated the diagnostic potential of HNF4α for detecting endocervical glandular lesions (EGLs), including endocervical adenocarcinomas (ECAs), adenocarcinomas in situ (AIS), and lobular endocervical glandular hyperplasias (LEGH)
Yuri Noda, Kaori Sando, Masato Kita, Koji Tsuta   +3 more
wiley   +1 more source

Lactylation-related risk model for prognostication and therapeutic responsiveness in uterine corpus endometrial carcinoma. [PDF]

Discov Oncol
Yin Y, Luo M.
europepmc   +1 more source

A Genetic Twist: Cytologic Evaluation of Pancreatic Adenocarcinoma and Steatohepatitic Hepatocellular Carcinoma in a Patient With a Rare POLE Mutation

Diagnostic Cytopathology, Volume 53, Issue 8, Page E160-E164, August 2025.
ABSTRACT Mutations in the DNA polymerase epsilon (POLE) gene are associated with an increased risk of various malignancies, including colorectal and other gastrointestinal, endometrial, ovarian, breast, and brain cancers. In extremely rare cases, POLE mutations have also been associated with pancreatic and hepatobiliary carcinomas.
Lynn Messersmith, Areeba H. Rizvi, Dina El‐Rayes, Jimmie Stewart III   +3 more
wiley   +1 more source

ARNTL-mediated INO80-DHX15 axis reprograms the glycolytic metabolism and augments the progression of endometrial carcinoma. [PDF]

Cell Death Dis
Ye L, Jiang G, Sun Y, Li B.
europepmc   +1 more source

Detection of PTEN Mutations in Fine Needle Aspiration Biopsies of Indeterminate Thyroid Nodules: Impact on Diagnosis and Prognosis

Head &Neck, Volume 47, Issue 8, Page 2145-2151, August 2025.
ABSTRACT Background Data connecting PTEN mutations with thyroid cancer risk for indeterminate nodules remain limited due to the rare nature of these mutations. The aim of this study was to determine the relationship between PTEN mutations identified in cytologically indeterminate nodules and final pathology and clinical outcomes.
Lauren E. Schlegel, Madelaine Brill‐Edwards, Zi‐Xuan Wang, Christopher McNair, Stacey Gargano, Elizabeth Cottrill   +5 more
wiley   +1 more source

Expression and prognosis of NR3C1 in uterine corpus endometrial carcinoma based on multiple datasets. [PDF]

Discov Oncol
Shen Y, Yang P, Lu Y.
europepmc   +1 more source

Cytological of endometrial carcinoma. The accuracy of endometrial cytology.

, 2000
Toshiko Jobo, R Sato, Tadayuki Kanai, Manami Imai, Hiroyuki Kuramoto, Eiji Ohno   +5 more
openalex   +2 more sources

Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer

International Journal of Cancer, Volume 157, Issue 3, Page 480-489, 1 August 2025.
What's new? In this prospective study, the authors evaluated the discrimination capacity of 92 cancer‐related proteins as potential early detection biomarkers for endometrial cancer using blood samples from two large‐scale European population cohorts (EPIC and Janus).
Victoria Cooley, Renée Turzanski Fortner, Trasias Mukama, Sabine Naudin, Valeria Pala, Laure Dossus, Inger T. Gram, Karina Standahl Olsen, Maria‐Jose Sánchez, Pernilla Israelsson, Naomi Allen, Hilde Langseth, Rudolf Kaaks   +12 more
wiley   +1 more source

Long sustained response during second-line pembrolizumab plus lenvatinib in a patient with recurrent endometrial carcinoma: a case report. [PDF]

Drugs Context
Fabbri L, Galvani L, Zamagni C.
europepmc   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 16 No. 1 [PDF]

, 1980

core   +1 more source